RH Stock Surpasses Analyst Target Price: What’s Next?
Recent trading data shows that shares of RH (Symbol: RH) have surpassed the average analyst 12-month target price of $330.29, currently selling for $336.80 per share. When a stock hits an analyst’s projected target, there are typically two reactions: a downgrade of the stock’s value or an adjustment of the target price upwards. Analysts’ responses often hinge on recent business developments that might influence the stock’s upward trajectory. If the company’s prospects are improving, it could be time to elevate that target price.
A total of 17 analysts contribute to the average target for RH, creating a broad base of opinions. While the average is $330.29, this figure represents a mathematical midpoint. Notably, one analyst has set a low target of $226.00, while another has set a much higher target at $430.00. The standard deviation among these targets is $57.161, indicating that opinions on RH’s valuation vary significantly.
Considering the average target price for RH gives investors a chance to tap into a “wisdom of crowds” effect, uniting the insights of multiple analysts instead of relying on a single opinion. Now that RH shares have crossed the average target price, investors are prompted to reevaluate the company’s current standing. They must decide: is $330.29 merely a stepping stone towards a greater goal, or is the valuation stretched too thin, suggesting it’s time to consider selling some shares? Below is a detailed breakdown of current analyst ratings for RH:
| Recent RH Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
| Strong buy ratings: | 9 | 8 | 8 | 8 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 9 | 10 | 10 | 10 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 1 | 1 | 1 | 1 |
| Average rating: | 2.16 | 2.26 | 2.26 | 2.26 |
The average rating in the table above ranges from 1 to 5, with 1 assigned as Strong Buy and 5 as Strong Sell. This analysis utilized data from Zacks Investment Research via Quandl.com. For further insights, access the latest Zacks research report on RH—at no cost.
Explore the Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
• Top Broker Analyst Picks
• MDB Options Chain
• Intuitive Surgical market cap history
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
